dr. sweeney on evolving role of chemotherapy for hormone-sensitive prostate cancer
Published 9 years ago • 197 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
1:09
dr. sweeney on chemotherapy in prostate cancer
-
2:32
dr. sweeney on the optimal use of cabazitaxel
-
0:48
dr. kantoff on evolving role of docetaxel in prostate cancer treatment
-
1:55
dr. sweeney on chemotherapy versus abiraterone for mcrpc
-
3:21
the evolving role of chemotherapy for the management of advanced prostate cancer
-
1:02
dr. oh discusses the role of chemotherapy in prostate cancer
-
1:43
dr. oh on the role of docetaxel in metastatic hormone-sensitive prostate cancer
-
2:46
dr. sweeney on the phase iii enzamet trial in metastatic hormone-sensitive prostate cancer
-
1:14
dr. kelly discusses the role of chemotherapy in castration-resistant prostate cancer
-
1:57
the evolving treatment landscape of prostate cancer
-
9:22
christopher sweeney, et al.
-
1:45
dr. sweeney discusses tailoring treatment in prostate cancer
-
1:18
dr. sweeney on the future of prostate cancer research
-
21:16
prolonging survival in early chemo-sensitive populations - christopher sweeney
-
2:47
william oh, md: the role of chemotherapy and local therapy
-
1:19
role of the addition of docetaxel to adt in mhspc
-
1:38
christopher sweeney on adt combination therapies for prostate cancer
-
1:19
significance of a phase iii study on docetaxel with hormonal & radiation therapy in prostate cancer
-
55:35
is there still a role for docetaxel in mhspc?